Cell and Gene Therapy (CGT): Pre-launch checklist
As they embark on the commercialization path, it is essential for cell and gene therapy (CGT) developers, who invest their time, expertise, and financial resources to create groundbreaking therapies that profoundly impact patients' lives, to position themselves for optimal market access by engaging with the right stakeholders. Discover how selecting the right integrated commercialization solutions partner can help position your product for success.
The right partner will help streamline the intricate pre-launch process, assist you in tackling challenging decisions related to market access, distribution strategies, patient services, and more―ensuring all bases are covered.

Enter your information below to download the checklist and discover the ten questions to ask yourself and your commercialization partner to chart a comprehensive strategy that aims to support the successful advancement of your therapy.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.